Retinoids as preventive and therapeutic anticancer agents (Part I)

Area of Science:

• Oncology
• Biochemistry
• Pharmacology

Background:

• Retinoids, synthetic and natural vitamin A analogs, inhibit cancer cell growth and induce differentiation in vitro and in vivo.
• The protein kinase-C cascade system is emerging as a unifying mechanism for retinoid action across diverse cellular processes.
• Retinoids have demonstrated efficacy in preventing and treating various human cancers, including skin and non-dermatologic premalignancies.

Purpose of the Study:

• To elucidate the unifying mechanism of retinoid action, focusing on the protein kinase-C cascade system.
• To explore the potential of retinoids in cancer prevention and therapy for various malignancies.
• To assess the structure-activity relationships and synergistic potential of retinoids in combination treatments.

Main Methods:

• In vitro and in vivo assay systems for testing synthetic retinoids.
• Studies on retinoid structure-activity relationships and effects on oncogene expression.
• Investigation of the protein kinase-C cascade system's role in retinoid action.

Main Results:

• Retinoids effectively block cancer cell phenotypic expression, inhibit growth, and induce differentiation.
• The protein kinase-C cascade system mediates diverse retinoid actions, including effects on gene expression and immunologic responses.
• Newer generation retinoids show higher therapeutic indexes, and retinoids exhibit synergistic activity with other agents and modalities.

Conclusions:

• Retinoids represent a promising class of drugs for cancer prevention and treatment, with ongoing research clarifying their precise mechanisms.
• The protein kinase-C cascade system is crucial for understanding retinoid's anticancer effects.
• Further clinical trials and in vitro studies are warranted to optimize retinoid-based cancer therapies.